Silver Book Fact

Growth hormone treatment in patients with fibromyalgia is effective in reducing pain with sustained action over time.

Cuatrecasas G, Alegre C, Fernandez-Sola J, Gonzalez M, et al. Growth Hormone Treatment for Sustained Pain Reduction and Improvement in Quality of Life in Severe Fibromyalgia. Pain. 2012; 153(7): 1382-9. http://www.ncbi.nlm.nih.gov/pubmed/22465047

Reference

Title
Growth Hormone Treatment for Sustained Pain Reduction and Improvement in Quality of Life in Severe Fibromyalgia
Publication
Pain
Publication Date
2012
Authors
Cuatrecasas G, Alegre C, Fernandez-Sola J, Gonzalez M, et al.
Volume & Issue
Volume 153, Issue 7
Pages
1382-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • An opiate agonist often used for persistent pain, tramadol was found in one meta-analysis to significantly reduce neuropathic pain when compared to placebo.  
  • Topical clonidine gel significantly reduces foot pain in patients with painful diabetic neuropathy.  
  • A proteasome inhibitor was found to reduce pain and joint destruction in an animal model of osteoarthritis, suggesting that nontoxic proteasome inhibitors could offer a novel pharmacotherapy option.  
  • 60% of people with persistent back pain who turned to complementary and alternative medicine perceived a “”great deal”” of benefit.  
  • In individuals with persistent low back pain, tanezumab, a humanized anti-nerve growth factor antibody, showed clinical and statistical analgesic efficacy that was superior to placebo and naproxen.